Liothyronine Sodium Tablet
Product Images NDC 43063-884

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 43063-884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063884)

This appears to be the packaging label of a medication containing Liothyronine Sodium, with a recommended dosage of one tablet taken several times a day, as well as storage instructions and a warning to keep it out of the reach of children. It also includes the NDC number, lot number, expiration date, and contact information for reporting side effects to the FDA.*

FDA Label Image

Image Description (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.